KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Current Assets (2016 - 2025)

Historic Current Assets for Pacific Biosciences Of California (PACB) over the last 17 years, with Q3 2025 value amounting to $394.2 million.

  • Pacific Biosciences Of California's Current Assets fell 3252.09% to $394.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $394.2 million, marking a year-over-year decrease of 3252.09%. This contributed to the annual value of $495.7 million for FY2024, which is 3320.09% down from last year.
  • Pacific Biosciences Of California's Current Assets amounted to $394.2 million in Q3 2025, which was down 3252.09% from $413.4 million recorded in Q2 2025.
  • Pacific Biosciences Of California's Current Assets' 5-year high stood at $1.2 billion during Q1 2021, with a 5-year trough of $394.2 million in Q3 2025.
  • In the last 5 years, Pacific Biosciences Of California's Current Assets had a median value of $882.3 million in 2023 and averaged $819.0 million.
  • Its Current Assets has fluctuated over the past 5 years, first skyrocketed by 68782.55% in 2021, then plummeted by 3428.25% in 2025.
  • Pacific Biosciences Of California's Current Assets (Quarter) stood at $1.1 billion in 2021, then decreased by 22.62% to $852.1 million in 2022, then fell by 12.91% to $742.0 million in 2023, then tumbled by 33.2% to $495.7 million in 2024, then decreased by 20.47% to $394.2 million in 2025.
  • Its Current Assets was $394.2 million in Q3 2025, compared to $413.4 million in Q2 2025 and $444.9 million in Q1 2025.